Aging and intellectual disability: Insights from mouse models of down syndrome

Developmental Disabilities Research Reviews

Volumn 18, Issue 1, 2013, Pages 43-50

  Ruparelia, Aarti ^a   Pearn, Matthew L ^b,c   Mobley, William C ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aging; Down syndrome; Intellectual disability; mouse models; Ts65dn

Indexed keywords

AGING; ALZHEIMER DISEASE; AMNESIA; BRAIN; COGNITIVE DEFECT; DEMENTIA; DOWN SYNDROME; FETAL ALCOHOL SYNDROME; FRAGILE X SYNDROME; HYPOXIA; INFECTION; INTELLECTUAL IMPAIRMENT; INTERPERSONAL COMMUNICATION; LANGUAGE; LONGEVITY; MORTALITY; NERVE DEGENERATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; WILLIAMS BEUREN SYNDROME;

AGING; DOWN SYNDROME; INTELLECTUAL DISABILITY; MOUSE MODELS; TS65DN;

ADULT; AGING; ALZHEIMER DISEASE; ANIMALS; ANTIGENS, CD24; BEHAVIOR, ANIMAL; COGNITION DISORDERS; DEMENTIA; DISEASE MODELS, ANIMAL; DOWN SYNDROME; HUMANS; INTELLECTUAL DISABILITY; LONGEVITY; MEMORY DISORDERS; MICE; TRISOMY; UP-REGULATION;

EID: 84893499405     PISSN: 19405510     EISSN: 19405529     Source Type: Journal    
DOI: 10.1002/ddrr.1127     Document Type: Review

References (87)

1. Abbeduto L, Warren SF, Conners FA. 2007. Language development in Down syndrome: from the prelinguistic period to the acquisition of literacy. Ment Retard Dev Disabil Res Rev 13:247-261
2. Ait Yahya-Graison E, Aubert J, Dauphinot L, et al. 2007. Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes Am J Hum Genet 81(3):475-491
3. Aldridge K, Reeves RH, Olson LE, et al. 2007 Differential effects of trisomy on brain shape and volume in related aneuploid mouse models. Am J Med Genet A 143A:1060- 1070
4. Antonarakis SE, Lyle R, Dermitzakis ET, et al 2004. Chromosome 21 and down syndrome: from genomics to pathophysiology Nat Rev Genet 5:725-738
5. Aylward EH, Habbak R, Warren AC, et al 1997. Cerebellar volume in adults with Down syndrome. Arch Neurol 54:209-212
6. Ball MJ, Nuttall K. 1980. Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in Down Syndrome: quantitative comparison with Alzheimer dementia. Ann Neurol 7:462-465
7. Beacher F, Daly E, Simmons A, et al. 2010. Brain anatomy and ageing in non-demented adults with Down's syndrome: an in vivo MRI study. Psychol Med 40:611-619
8. Belichenko NP, Belichenko PV, Kleschevnikov AM, et al. 2009. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci 29:5938-5948
9. Bittles AH, Bower C, Hussain R, et al. 2007 The four ages of Down syndrome. Eur J Public Health 17:221-225
10. Bittles AH, Glasson EJ. 2004. Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol 46:282-286
11. Bittles AH, Petterson BA, Sullivan SG, et al 2002. The influence of intellectual disability on life expectancy. J Gerontol A Biol Sci Med Sci 57:M470-M472
12. Brown M, Duff H, Karatzias T, et al. 2011. A review of the literature relating to psychological interventions and people with intellectual disabilities: issues for research, policy, education and clinical practice. J Intellect Disabil 15:31-45
13. Cabrejo L, Guyant-Marechal L, Laquerriere A, et al. 2006. Phenotype associated with APP duplication in five families. Brain 129(Pt 11):2966-2976
14. Carlesimo GA, Marotta L, Vicari S. 1997. Longterm memory in mental retardation: evidence for a specific impairment in subjects with Down's syndrome. Neuropsychologia 35(1):71-79
15. Cataldo AM, Barnett JL, Pieroni C, et al. 1997 Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis J Neurosci 17:6142-6151
16. Cataldo AM, Mathews PM, Boiteau AB, et al 2008. Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects. Am J Pathol 173(2):370-384
17. Cataldo AM, Petanceska S, Peterhoff CM, et al 2003. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome. J Neurosci 23: 6788-6792
18. Cataldo AM, Petanceska S, Terio NB, et al 2004. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome Neurobiol Aging 25:1263-1272
19. Chakrabarti L, Best TK, Cramer NP, et al. 2010 Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome Nat Neurosci 13(8):927-934
20. Chang KT, Min KT. 2009. Upregulation of three Drosophila homologs of human chromosome 21 genes alters synaptic function: implications for Down syndrome. Proc Natl Acad Sci USA 106:17117-17122
21. Choi JH, Berger JD, Mazzella MJ, et al. 2009 Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model. J Neurochem 110: 1818-1827
22. Cooper JD, Salehi A, Delcroix JD, et al. 2001 Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion. Proc Natl Acad Sci USA 98:10439-10444
23. Coppus A, Evenhuis H, Verberne GJ, et al. 2006 Dementia and mortality in persons with Down's syndrome. J Intellect Disabil Res 50(Pt 10):768-777
24. Das I, Reeves RH. 2011. The use of mouse models to understand and improve cognitive deficits in Down syndrome. Dis Model Mech 4:596-606
25. Dierssen M, Herault Y, Estivill X. 2009. Aneuploidy: From a physiological mechanism of variance to Down syndrome. Physiol Rev 89: 887-920
26. Fernandez F, Garner CC. 2007. Object recognition memory is conserved in Ts1Cje, a mouse model of Down syndrome. Neurosci Lett 421:137-141
27. Fernandez F, Morishita W, Zuniga E, et al. 2007 Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci 10:411-413
28. Freeman SB, Bean LH, Allen EG, et al. 2008 Ethnicity, sex, and the incidence of congenital heart defects: a report from the National Down Syndrome Project. Genet Med 10: 173-180
29. Glasson EJ, Sullivan SG, Hussain R, et al. 2002 The changing survival profile of people with Down's syndrome: implications for genetic counselling. Clin Genet 62:390-393
30. Glasson EJ, Sullivan SG, Hussain R, et al. 2003 Comparative survival advantage of males with Down syndrome. Am J Hum Biol 15: 192-195
31. Granholm AC, Sanders LA, Crnic LS. 2000. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome. Exp Neurol 161:647-663
32. Harlow SD, Ephross SA. 1995. Epidemiology of menstruation and its relevance to women's health. Epidemiol Rev 17:265-286
33. Hasle H. 2001. Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol 2:429-436
34. Hassold T, Abruzzo M, Adkins K, et al. 1996 Human aneuploidy: incidence, origin, and etiology. Environ Mol Mutagen 28:167-175
35. Hattori M, Fujiyama A, Taylor TD, et al. 2000 The DNA sequence of human chromosome 21. Nature 405:311-319
36. Hill CA, Sussan TE, Reeves RH, et al. 2009 Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic "Down syndrome" mice. Am J Med Genet A 149A:2158-2165
37. Hodapp RM. 2007. Families of persons with Down syndrome: new perspectives, findings, and research and service needs. Ment Retard Dev Disabil Res Rev 13:279-287
38. Holland AJ, Hon J, Huppert FA, et al. 2000 Incidence and course of dementia in people with Down's syndrome: findings from a population-based study. J Intellect Disabil Res 44 (Pt 2):138-146
39. Holtzman DM, Santucci D, Kilbridge J, et al 1996. Developmental abnormalities and agerelated neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci USA 93:13333-13338
40. Hunter CL, Isacson O, Nelson M, et al. 2003 Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome Neurosci Res 45:437-445
41. Ishihara K, Amano K, Takaki E, et al. 2010 Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome. Cereb Cortex 20:1131-1143
42. Jarrold C, Baddeley AD, Phillips C. 1999. Down syndrome and the phonological loop: the evidence for, and importance of, a specific verbal short-term memory deficit. Downs Syndr Res Pract 6:61-75
43. Jiang Y, Mullaney KA, Peterhoff CM, et al 2010. Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc Natl Acad Sci USA 107:1630-1635
44. Johannsen P, Christensen JE, Mai J. 1996. The prevalence of dementia in Down syndrome Dementia 7:221-225
45. Kesslak JP, Nagata SF, Lott I, et al. 1994. Magnetic resonance imaging analysis of agerelated changes in the brains of individuals with Down's syndrome. Neurology 44: 1039-1045
46. Korbel JO, Tirosh-Wagner T, Urban AE, et al 2009. The genetic architecture of Down syndrome phenotypes revealed by highresolution analysis of human segmental trisomies Proc Natl Acad Sci USA 106:12031- 12036
47. Larson J, Jessen RE, Kim D, et al. 2005. Agedependent and selective impairment of longterm potentiation in the anterior piriform cortex of mice lacking the fragile X mental retardation protein. J Neurosci 25:9460- 9469
48. Lotan M, Merrick J, Kandel I, et al. 2010. Aging in persons with Rett syndrome: an updated review. ScientificWorldJournal 10:778-787
49. Lott IT, Dierssen M. 2010. Cognitive deficits and associated neurological complications in individuals with Down's syndrome. Lancet Neurol 9:623-633
50. Lyle R, Bena F, Gagos S, et al. 2009. Genotypephenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J Hum Genet 17:454-466
51. McGraw CM, Samaco RC, Zoghbi HY. 2011 Adult neural function requires MeCP2. Science 333:186
52. Morice E, Andreae LC, Cooke SF, et al. 2008 Preservation of long-term memory and synaptic plasticity despite short-term impairments in the Tc1 mouse model of Down syndrome. Learn Mem 15:492-500
53. Morris CD, Magilke D, Reller M. 1992. Down's syndrome affects results of surgical correction of complete atrioventricular canal Pediatr Cardiol 13:80-84
54. Nadel L. 2003. Down's syndrome: a genetic disorder in biobehavioral perspective. Genes Brain Behav 2:156-166
55. O'Doherty A, Ruf S, Mulligan C, et al. 2005. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes Science 309:2033-2037
56. Olson LE, Roper RJ, Sengstaken CL, et al. 2007 Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice. Hum Mol Genet 16:774-782
57. Pereira PL, Magnol L, Sahun I, et al. 2009. A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome. Hum Mol Genet 18:4756-4769
58. Pinter JD, Brown WE, Eliez S, et al. 2001a Amygdala and hippocampal volumes in children with Down syndrome: a highresolution MRI study. Neurology 56:972- 974
59. Pinter JD, Eliez S, Schmitt JE, et al. 2001b. Neuroanatomy of Down's syndrome: a highresolution MRI study. Am J Psychiatry 158: 1659-1665
60. Prandini P, Deutsch S, Lyle R, et al. 2007. Natural gene-expression variation in Down syndrome modulates the outcome of genedosage imbalance. Am J Hum Genet 81: 252-263
61. Prasher VP, Chowdhury TA, Rowe BR, et al 1997. ApoE genotype and Alzheimer's disease in adults with Down syndrome: metaanalysis Am J Ment Retard 102:103-110
62. Reeves RH, Irving NG, Moran TH, et al. 1995 A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 11:177-184
63. Rondal JaC, A. 1996. Language in adults with Down syndrome. Down Syndrome Res Pract 4:3-14
64. Rovelet-Lecrux A, Hannequin D, Raux G, et al 2006. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24-26
65. Ruparelia A, Pearn ML, Mobley WC. 2012 Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndrome Curr Opin Neurobiol 22:880-886
66. Ryoo SR, Jeong HK, Radnaabazar C, et al 2007. DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease. J Biol Chem 282:34850-34857
67. Sago H, Carlson EJ, Smith DJ, et al. 1998 Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci USA 95:6256-6261
68. Sago H, Carlson EJ, Smith DJ, et al. 2000 Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome. Pediatr Res 48:606- 613
69. Salehi A, Delcroix JD, Belichenko PV, et al 2006. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 51:29-42
70. Salehi A, Faizi M, Colas D, et al. 2009. Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome. Sci Transl Med 1:7ra17
71. Seltzer GB, Schupf N, Wu HS. 2001. A prospective study of menopause in women with Down's syndrome. J Intellect Disabil Res 45(Pt 1):1-7
72. Shukkur EA, Shimohata A, Akagi T, et al. 2006 Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome. Hum Mol Genet 15: 2752-2762
73. Singh K, Gaur P, Prasad S. 2007. Fragile x mental retardation (Fmr-1) gene expression is down regulated in brain of mice during aging Mol Biol Rep 34:173-181
74. Singh K, Prasad S. 2008. Differential expression of Fmr-1 mRNA and FMRP in female mice brain during aging. Mol Biol Rep 35: 677-684
75. Sleegers K, Brouwers N, Gijselinck I, et al. 2006 APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy. Brain 129(Pt 11):2977- 2983
76. Smigielska-Kuzia J, Sobaniec W, Kulak W, et al 2009. Clinical and EEG features of epilepsy in children and adolescents in Down syndrome J Child Neurol 24:416-420
77. Stanton LR, Coetzee RH. 2004. Down's syndrome and dementia. Adv Psychiatr Treat 10:50-58
78. Sturgeon X, Gardiner KJ. 2011. Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions Mamm Genome 22(5-6):261-271
79. Teipel SJ, Schapiro MB, Alexander GE, et al 2003. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome. Am J Psychiatry 160:1870-1878
80. Utari A, Adams E, Berry-Kravis E, et al. 2010 Aging in fragile X syndrome. J Neurodev Disord 2:70-76
81. Van Buggenhout GJ, Trommelen JC, Schoenmaker A, et al. 1999. Down syndrome in a population of elderly mentally retarded patients: genetic-diagnostic survey and implications for medical care. Am J Med Genet 85:376-384
82. Vicari S, Carlesimo GA. 2006. Short-term memory deficits are not uniform in Down and Williams syndromes. Neuropsychol Rev 16: 87-94
83. Wechsler J, Greene M, McDevitt MA, et al 2002. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome Nat Genet 32:148-152
84. Yang Q, Rasmussen SA, Friedman JM. 2002 Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 359:1019- 1025
85. Yu T, Li Z, Jia Z, et al. 2010a. A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions. Hum Mol Genet 19:2780-2791
86. Yu T, Liu C, Belichenko P, et al. 2010b. Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice. Brain Res 1366:162-171
87. Zigman WB, Jenkins EC, Tycko B, et al. 2005 Mortality is associated with apolipoprotein E epsilon4 in nondemented adults with Down syndrome. Neurosci Lett 390:93-97